| Insider | Venker Eric |
|---|---|
| Title | President & Immunovant CEO |
| Transaction Date | May 20, 2026 |
| Transaction Code | F Tax Withholding |
| Acquired/Disposed | Disposed |
| Security | Common Shares |
| Direct/Indirect | Direct |
| Filing Date | May 22, 2026 |
| Shares Purchased | 34,483 |
| Price per Share | $32.41 |
| Total Value | $1,117,594.03 |
| Shares Owned After | 1,613,063 |
| Derivative | No |
| Accession Number | 0001635088-26-000065 |
| Document | View SEC Filing |